Insider Purchases: Inside the Buy

Tag: medical device stocks

CooperCompanies COO stock analysis showing $1.33M insider buying near $53, record $273M free cash flow and a $3B buyback plan.

👁️ CooperCompanies (COO): Insiders Buy $1.33M at $53–$54 as the Stock Crashes

Three CooperCompanies directors just put $1.33 million of their own money into COO near $53–$54. Add record $273M free cash flow, an expanded $3B buyback authorization and an 11.1× forward P/E—and this beaten-down medtech stock deserves a much closer look. 👁️

 

Read entire article

Tags: buy or sell COO, CarpeDiem, contact lenses, COO, COO stock, CooperCompanies, CooperCompanies stock, CooperSurgical, CooperVision, featured-insiders, featured-value, fertility stocks, free cash flow, FUNanc1al, FunStock Index, healthcare stocks, hub-insiders, hub-value, insider buying, insider purchases, insider trading, InsiderBuying, medical device stocks, MedTech, medtech stocks, PEG ratio, risks buying COO, share repurchases, ShareBuyback, stock buybacks, undervalued stocks, value stocks, ValueInvesting, why buy COO
Cinematic illustration of Boston Scientific as a futuristic medtech powerhouse, with glowing cardiovascular devices, a heart-shaped stock chart, doctors, investors, and a $2B buyback shield symbolizing healthcare innovation and a GARP stock opportunity.

🫀 Boston Scientific (BSX): A GARP Reset on a Medical Device Powerhouse

Boston Scientific stock has fallen nearly 48% from its highs, but the business engine remains strong. With double-digit revenue growth, major cardiovascular catalysts, director insider buying, low short interest, and a $2B buyback, BSX may be one of the cleaner large-cap healthcare GARP setups on the market.

Read entire article

Tags: Boston Scientific, BostonScientific, BSX, BSX stock, buy or sell BSX, cardiovascular devices, CardiovascularTech, dividend growth stocks, FARAPULSE, featured-insiders, FUNanc1al, GARP, GARP investing, growth stocks, healthcare investing, healthcare stocks, hub-insiders, insider buying, InsiderBuying, medical device stocks, medical technology, MedicalDevices, MedTech, medtech stocks, NYSE BSX, risks buying BSX, ShareRepurchase, stock buyback, stock market analysis, value investing, ValueInvesting, WATCHMAN FLX, why buy BSX